The therapeutic effect of CASR on CHD was preliminarily evaluated by pharmacological verification, and the expression of the components of PI3K/AKT/mTOR signaling pathway, which was previously predicted, was further verified using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Here, MTOR is linked to coronary artery disorder.